Introduction improvement in myofiber cell transfection may provide Direct intramuscular injection of plasmid DNA in mice rationale for increased delivery of plasmid DNA to nonresults in the long-term transfection of resident skeletal muscle cells. Thus far, there has been no detailed study myofiber cells. 1, 2 Such persistent transfection by direct of the time course and pattern of intramuscular distri-DNA injection may provide human therapeutic opportbution of plasmid expression. In this study, the macrounities. In animal models, intramuscular injection of scopic and microscopic spatial-temporal distributions of DNA encoding: (1) antigens from known viruses, bacteria ␤-galactosidase expression in myofiber cells was or protozoans result in the protection against a subexamined following lacZ plasmid DNA injection into the sequent challenge with the corresponding pathogen; [3] [4] [5] [6] [7] mouse rectus femoris muscle. (2) tumor-specific antigens result in protection of mice against challenges with tumorigenic cells expressing the corresponding antigen; 8, 9 (3) secreted proteins result in
Results
protein delivery into the bloodstream; [10] [11] [12] and (4) normal dystrophin results in the expression of the normal
To estimate an optimal dosage of DNA and to select repdystrophin in segments of dystrophic myofiber cells. 13 resentative post-DNA injection times, dose-response and Furthermore, plasmid DNA can be engineered to time course of expression analyses were conducted using respond to regulation by systemically administered the luciferase encoding plasmid, VR1207. The results are drugs. 14, 15 Future human therapeutic applications of shown in Figure 1 . At 7 days after injection, a maximal direct intramuscular injection of regulatable plasmid level of luciferase expression in mouse rectus femoris was DNAs may include injection of DNA encoding anti-obese reached after a single injection dose of 50-250 g DNA proteins, 16 insulin, 17 genetic disease-related circulating per muscle ( Figure 1a) . A time-course analysis, shown in enzymes 18 or neurotrophic factors. 19 Figure 1b, revealed that luciferase expression was readily A detailed understanding of the extent to which skeldetected at 1 day after injection, after which it peaked at etal muscle becomes transfected will set a baseline for 7 days, and then declined to stabilize at levels of 82-344 further work in improving muscular transfection by plaspg per muscle for at least 180 days (longest time tested). mid DNA injection and encourage the use of direct DNA A short-term expression study, shown in Figure 1c , indicated that luciferase expression could be easily detected within 0.5 h after DNA injection, after which luciferase activity rose steadily for 24 h. Based on the luciferase compared with the quantitative expression pattern described earlier for muscles injected with an equivalent luciferase DNA vector (compare Figure 2 with Figure 1b ). According to Figure 1b , 1-day luciferase expression levels were about one-third of 7-day expression levels (9227 versus 28 143 pg per muscle). The 28-day luciferase expression was quantitatively similar to 56 day expression levels (295 versus 344 pg per muscle). The corresponding 1-, 7-and 30-day X-gal staining patterns appeared qualitatively comparable with the quantitative luciferase plasmid DNA injection results. In contrast to the luciferase results, the 60-day X-gal levels were considerably lower than the 30-day levels. Twelve muscles injected with VR1207 served as negative controls and all were X-gal negative (data not shown). No X-gal staining was observed in non-DNA injected muscles. The overall pattern of rectus femoris X-gal staining shown in Figure 2 was elongated and tubular and by 3 days the staining appeared as strands that often extended across two-thirds of the muscle length. None of the muscles appeared to be grossly damaged by observation under a dissecting microscope. No preferential expression was observed near the injection sites at the distal end of the muscle (shown as 'x' in the day 1 muscles in Figure 2 ). Most of the muscles contained Xgal-positive strands that appeared to terminate abruptly (eg Figure 2 , day 3 No. 6, day 7 No. 1, day 14 No. 1). Some muscles also contained strands that were more intensely stained in central regions, but showed decreasing staining along the fiber length (eg Figure 2, muscle cross-sections occurred almost exclusively in the rectus femoris muscle, while the adjacent vastus muscles contained few, if any, X-gal-positive cells (data not expression was examined at various times between 3 h and 60 days after DNA injection.
shown). Preliminary experiments with India ink injections showed that the ink was restricted to, and generally Wholemount X-gal staining was used to assess the gross three-dimensional pattern of lacZ expression in recdistributed throughout, the rectus femoris muscle. Previous studies using PCR showed that little, if any, naked tus femoris muscles at different times after injection. One hundred and forty rectus femoris muscles were injected DNA escapes the muscle to transfect other tissues. 20 Microscopic examination revealed that X-gal staining was with 50 g of VR1405 lacZ DNA in 50 l saline. Twenty muscles were collected for each time-point at 6 h and 1, consistently located in myofiber cells ( Figure 3) . None of the rectus femoris muscle cross-sections exhibited a uni-3, 7, 14, 30 and 60 days after injection, processed for wholemount X-gal staining and photographed. Eight repform distribution of X-gal-positive myofibers across the muscle cross-section. Instead, X-gal-stained myofibers resentative muscles for each time-point (except 6 h) are shown in Figure 2 . X-gal staining was readily detected at were usually clustered in a relatively small crosssectional area (about 10% of the total area), and usually 1 day, and maximal expression was observed at 3, 7 and 14 days. By 30 and 60 days, muscles exhibited lower but in the vicinity of the proximal tendon which extends twothirds of the way into the rectus femoris and represents easily detectable X-gal staining. This temporal ␤-galactosidase expression pattern in wholemount muscles was the proximal insertion point for all rectus femoris myofibers (note arrows in Figure 3 that trace the position which represents from 0.1% to 15.4% of the total number of 4000 rectus femoris myofiber cells determined by hemof the proximal tendon). X-gal-positive myofiber cells were usually located almost exclusively on one side of atoxylin and eosin staining and counting. An average of 239 myofibers, or 5.9% of the 4000 fibers present, were the proximal tendon sheath (Figure 3a-d) . Occasionally, X-gal-positive fibers were distributed predominantly on X-gal-positive after this single injection of lacZ plasmid DNA. Of the 20 muscles examined, eight muscles (Table  one side, but with a significant number of positive fibers on the other side of the tendon sheath (Figure 3e-g ). In 1, Nos 13-20) exhibited less than 80 X-gal-positive fibers per section while the remaining 12 exhibited over 210 Xall muscles, individually transfected myofibers exhibited faint, medium or intense X-gal staining, and intensely gal-positive fibers (Table 1 , Nos 1-12). Thus, the distribution of X-gal positive cell numbers appears to be nonstained fibers were often adjacent to unstained ones (Figure 3h ). In areas where most of the X-gal-positive normal with a skewing of values toward lower transgene expression, in agreement with the more extensive quantifibers were localized, almost 70% of the fibers were X-gal positive. For example, the area surrounded by the dotted tative analysis reported using many different luciferase expression vectors. 21 line in Figure 3h (a higher magnification of Figure 3d ) contains 110 X-gal-positive fibers and 50 X-gal-negative To determine where, within the muscle, lacZ expression first appears and whether different areas of fibers.
The total number of X-gal-positive myofibers within the muscle show preferential or persistent expression, representative muscles were selected from those shown each of the 20 muscles was determined by microscopic counts and the data are shown in Table 1 . X-gal-positive in Figure 2 and individual or clusters of myofibers were dissected for microscopic examination. In addition, 10 myofiber cell numbers ranged from 3 to 615 per section, ). DNA encoding nuclear-targeted muscles showed staining to be restricted exclusively to areas where the myofibers terminated at the proximal ␤-galactosidase injected muscles exhibited a punctate and clustered staining that was more intense than that tendon sheath (Figure 4d 
(a-g) Proximal tendon sheath is outlined with arrows for each muscle. Note that most X-gal-positive myofiber cells are located in one region of each muscle. The section area encircled in (h) by a dotted line is a muscle region where about 70% of muscle fibers are X-gal positive. Panel (h) is a higher magnification of the field shown in (d). The X-gal staining intensity among X-gal-positive myofiber cells was faint, medium or strong. Magnification bars = 500 m in (a-g) and 200 m in (h).
Muscles collected at the 7 and 14 day time-points are cytoplasmic ␤-galactosidase exhibited staining at the 30-60 day time-points. Representative results are shown in Figure 8 . Individual myofiber cells dissected from intact muscles exhibited diffuse X-gal staining that usually terminated at the myotendinous junction (Figure 8a Many muscles at 30 and 60 days after the injection of the DNA encoding cytoplasmic ␤-galactosidase exhibited Muscles collected from the 3-and 4-day time-points are shown in Figure 6 . Most of the punctate X-gal staining evidence of inflammation and myofiber degeneration. Representative photographs are shown in Figure 9 . of the muscles expressing cytoplasmic ␤-galactosidase seen at earlier time-points was no longer apparent.
Often, muscles contained apparent myofiber cells containing alternating high and low intensity X-gal staining, Myofiber staining was more intense and extended over much longer distances than at the previous time-points resembling 'beads on a string' (Figure 9a-c) . Dissection and nuclear fast red counterstaining of such X-gal-posi- (Figure 6a-c) . Intracellular staining appeared to extend from the proximal tendon sheath all the way to the distal tive myofibers revealed them to be degenerating and to be associated with infiltrating cells (Figure 9d-g, arrows) . epimysial sheath (Figure 6a ). Dissected myofiber cells exhibited uniform staining nearly along their entire cell Some fibers appeared to have adjacent areas of low and high intensity X-gal staining (Figure 9c ,d,f) as if ␤-length (Figure 6d-f) . X-gal staining fibers appeared to exhibit an uninterrupted sarcomeric structure (Figure 6d galactosidase had been released into the extracellular space (Figure 9g ). Some fibers appeared to be in later f). Some fibers exhibited a 'band' of X-gal staining that seemed to encircle myofibers (Figure 6d,e, arrows) . The stages of degeneration (Figure 9g ). X-gal staining of muscles expressing nuclear-targeted ␤-galactosidase remained punctate and concentrated in Discussion clusters of nearby myofibers (Figure 6g,h,i) . Individual myofiber cells could sometimes be seen from the muscle Quantification studies using a luciferase reporter gene revealed that maximum expression occurred at 7 days surface to contain regions of adjacent X-gal-positive nuclei (Figure 6i) . Dissection of myofibers revealed mulafter injection of a single dose of 50 g of DNA. By 1 month after injection, luciferase expression decreased by tiple X-gal-positive nuclei clustered in the middle (Figure  6j ) or at the ends (Figure 6k ) of cells. The continuity of about two logs, but stabilized at this lower level for at least 6 months. Interestingly, luciferase expression was striated sarcomeric structure in dissected fibers indicated that the transfected myofiber cell membranes were not easily detectable at 30 min after DNA injection (eg Figure  1c) , and could even be detected in some muscles by grossly disrupted (Figure 6k ). 
b) Higher magnification of the entire muscle in (a), showing X-gal staining terminating in the proximal tendon region. Occasionally, some fibers show perinuclear staining as well as staining in central regions (arrows in c, d, f). (e and f) show fibers dissected from the muscle shown in (b) where X-gal staining is concentrated at myofiber ends (e) or in perinuclear regions (f). (g-m) Muscles injected with DNA encoding nuclear-targeted ␤-galactosidase. (g and h) are from the same muscle and show clusters of punctate staining. Staining is also seen in nuclei at myofiber termination regions (i, j) as well as in central fiber regions (k-m). Two adjacent fibers, one stained and one unstained are shown in (k and l). (a-c) derived from dissections of the muscle labeled day 1 No. 2 shown in Figure 2. Magnification bar = 3200 m in (a), (g); 530 m in (b), (c), (d), (h); 200 m in (e), (i), (j), (k), (l), (m); and 50 m in (f).

Figure 6 Spatial-temporal patterns of ␤-galactosidase expression in mouse rectus femoris muscle 3-4 days after lacZ DNA injections. (a-f) Muscles injected with DNA encoding cytoplasmic ␤-galactosidase. X-gal staining extends from myofiber ends to central regions in myofibers (a-c). Occasionally, individual X-gal-positive myofibers contain encircling 'band-shaped' staining (arrows in d,e). The striated sarcomeric structure of transfected myofibers appears intact (d-f). (g-k) Muscles injected with DNA encoding nuclear-targeted ␤-galactosidase. Clusters of X-galpositive nuclei can occur along individual myofibers at the muscle surface (arrows in (h)); (h) is a higher magnification of the muscle in (g). X-gal staining of nuclei along considerable lengths of individual fibers can occasionally be seen at the muscle surface (i). X-gal-positive nuclei occur at central (i, j) or terminal (k) myofiber regions and sarcolemmal striations remain intact (k). (a, b and d-f) are derived from dissections of the muscle labeled day 3 No. 4 in Figure 2. Magnification bar = 3200 m in (a), (c), (g); 1600 m in (b), (h), (i); 100 m in (j), (k); and 50 m in (d), (e), (f).
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Figure 7 Spatial-temporal patterns of ␤-galactosidase expression in mouse rectus femoris muscle 7-14 days after lacZ DNA injections. (a-f) Muscles injected with DNA encoding cytoplasmic ␤-galactosidase. The single fiber in the muscle pointed out in (a) (arrow) was dissected and is shown in (b). X-gal staining abruptly terminated at the point of myofiber insertion into the proximal tendon. Exclusive staining of central myofibers was not apparent due to the continuity of staining along the entire myofiber length (a-f). (g-l) Muscles injected with DNA encoding nuclear-targeted ␤-galactosidase. Note X-gal-positive nuclei at the terminal regions of myofibers (arrows in g, h). (i-l) Dissected X-gal-stained fibers show nuclear staining at myotendinous junctions (i-j) and occasionally in central (k,l) myofiber regions. (c, d and f) are derived from dissections of the muscle labeled day 7 No. 4, and (e) is derived from muscle day 7 No.7 shown as whole mounts in Figure 2. Magnification bar = 3200 m in (a), (c); 1070 m in (b), (e); 1600 m in (d), (g); 530 m in (f), (h); 100 m in (i), (l).
2 min after DNA injection (data not shown). Thus, some spatial distribution of lacZ expression. Furthermore, the proximal tendon of the rectus femoris is a flat pad-shaped injected luciferase DNA molecules were able to find their way into muscle cell nuclei, become transcribed into sheath which splays out into the central region of the muscle. This tendon could act as a physical barrier or RNA molecules which were then processed, exported from the nucleus and translated, all within moments after adhesive surface to the injected DNA which could elicit preferential myofiber transfection on only one side of the DNA injection. These data with luciferase DNA encouraged the use of the lacZ reporter gene to identify the tendon (cf Figure 3) . Such a tendon barrier may cause the DNA solution to accumulate on either side of the muscle, initially transfected cells and to track their temporal expression patterns.
and such an accumulation may permit a longer exposure of the DNA solution to the resident myofiber cells. ConAfter injection of lacZ plasmid DNA, muscle wholemount X-gal staining revealed that ␤-galactosidase sistent with this argument is the fact that the terminal ends of myofibers (ie myotendinous junction region) expression generally paralleled luciferase expression. That is, lacZ expression rose to a peak around 7 days after express gene product well before the central myofiber cell regions (cf Figure 4) . injection and declined to a lower level by 60 days after DNA injection. This temporal decline in expression may
We have found by gel analysis that most of the injected DNA degrades quickly after injection. 20 We found it techbe due to a systemic cytotoxic T cell response against myofiber cells expressing the xenogeneic proteins, firefly nically difficult, if not impossible, to determine how much and where the important DNA (ie DNA available luciferase and bacterial ␤-galactosidase. An anti-␤-galactosidase cytotoxic T lymphocytic immune response for transcription) accumulates within the rectus femoris. Standard methods such as DNA staining, in situ hybridizis generated after intramuscular lacZ DNA injections, and luciferase expression in athymic nude mice can be susation or PCR cannot distinguish low levels of nonnuclear, intact DNA from the great excess of partially tained at the peak 7-day levels for at least 9 months after intramuscular luciferase DNA injections (Hartikka et al, degraded DNA. Nevertheless, it is important to establish where intact DNA distributes within muscle. manuscript in preparation). In the present studies, the 30 and 60 day post-injection muscles, but not the 7-14 day Myofiber cells form invaginations and processes at the myotendinous junction making the sarcolemmal surface ones, show obvious cellular infiltration and degeneration of X-gal-positive myofiber cells, an appearance supportarea considerably larger than the surface area of the muscle cell in nonjunctional areas. [31] [32] [33] [34] The planes of T ing the presence of an antimyofiber immune response. Mature dystrophic or damaged myofiber cells can tubule networks are interrupted and open to the cell surface via myotendinous junction infoldings of the sarcoexpress MHC class I antigen. [22] [23] [24] [25] Thus, mature lacZtransfected myofiber cells may be able to present MHC lemma, and such openings assist inward diffusion of extracellular molecules at this area. 35, 36 Such anatomical class I antigen and become cellular targets of a cytolytic immune response. With regard to priming of the immune and physiological features of the myotendinous junction, coupled with the pooling at a tendon barrier and the response, recent studies with haplotypic mouse chimerae have provided good evidence that the myofiber cells hydraulic pressure created by the DNA solution, could well account for the preferential uptake and expression themselves are not directly responsible for the generation of immunity against transgene products, but more likely of DNA in myofiber areas attached to myotendinous junctions. Preliminary experiments using lacZ DNA injecprovide the transgene products to professional antigen presenting cells. [26] [27] [28] For DNA-based vaccine applition and wholemount X-gal staining of tibialis anterior muscles also show preferential expression at the myocations, such immune responses can lead to protection against infectious diseases.
3-7 For nonvaccine applitendinous junction areas (unpublished observations), although this muscle has not been examined in the same cations, it will be important to use genes encoding 'self' proteins to obviate such immune responses.
detail as the rectus femoris muscle. Nuclear-targeted ␤-galactosidase expressed from a Replicate muscles injected with lacZ DNA encoding cytoplasmic ␤-galactosidase exhibited spatially variable single transfected nucleus of cultured myotubes is reported to accumulate in nearby untransfected nuclei.
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X-gal staining patterns. Myofiber transfection was not restricted to the local area around the orifice of the injecThus, if a single nucleus were transfected with lacZ DNA in vivo in mature myofiber cells, the corresponding ␤-tion needle. Rather, staining occurred throughout the entire muscle, with most transfection seen in the proxigalactosidase may accumulate in nearby nuclei, thus demonstrating what has been termed a 'nuclear domain'. mal tendon, posterior epimysial sheath and distal collagen-rich regions, the latter two being extensions of Indeed, in the present in vivo study, many muscles injected with plasmid DNA encoding nuclear-targeted ␤-the patellar tendon. We and others 29, 30 have shown that India ink-injected muscle exhibited a similarly variable galactosidase exhibited staining patterns similar to the nuclear domain patterns reported for cultured myotubes. spatial distribution of dye well away from the injection site. Calculations show that a 50 l volume of injected
In the present studies, such nuclear domains appeared to extend for distances of 20 m to 1.2 mm along the DNA solution is almost 100 times more than the available extracellular space volume of the entire mouse rectus myofiber cell. Thus, this distance can be greater than the maximum 100 m nuclear domains reported for cultured femoris muscle. Since the injected DNA solution is accommodated by the muscle without significant backmyotubes. It is possible that ␤-galactosidase protein deriving from a single transfected nucleus is able to disflow through the needle tract, the DNA solution may physically distend the extracellular space in the muscle, tribute over much greater lengths than in cultured myotubes, possibly due to constant muscular contraction. probably longitudinally along paths of least adhesion or resistance. Such variable distention could result in the Alternatively, plasmid injections may result in transfection of myofiber nuclei all along the myofiber length. This DNA localizing in 'pockets' in variable parts of different muscles, and thus could explain the observed variable latter possibility is not supported by the present 659 observations that areas containing strongly X-gal-positive
Materials and methods
nuclei from nuclear-targeted lacZ injections remain, even Reagents weeks after transfection, at myofiber ends or in central Luciferase substrate (E1483) and lysis buffer (E153A) myofiber areas.
were from Promega (Madison WI, USA). Female 4 to 12-Dissection of individual myofibers suggested, based on week-old BALB/c mice were from Harlan Sprague an undisrupted sarcomeric structure, that X-gal-positive Dawley (San Diego, CA, USA). X-gal substrate solution myofibers were undamaged within hours of DNA injec-(5520UC) was from GIBCO/BRL (Gaithersburg, MD, tion. This finding supports the notion that the injected USA); glutaraldehyde (G-5882), paraformaldehyde DNA can enter mature, intact myofiber cells, and does (P6148), sodium deoxycholate (D-6750), Nonidet P-40 (Nnot support the notion that DNA only enters myofiber 0896), MgCl 2 (M-8266), potassium ferrocyanide (P-3289), cells via a grossly disrupted sarcolemma. Also, this findpotassium ferricyanide (P-3667,) N, N-dimethylformaming is consistent with previous reports 38, 39 that plasmid ide (D-8654), and dimethyl sulfoxide (DMSO; D-8779) DNA may be actively internalized by undamaged from Sigma (St Louis, MO, USA). myofiber cells via the T-tubule or caveolae systems. Alternatively, plasmid DNA may be taken up by active Plasmid DNA construction endocytic mechanisms. However, it is not clear from the
The four different plasmid DNAs used in the present present studies how some myofiber cells are transfected studies contained pUC backbones, CMV promoter while immediately adjacent myofibers remain untransenhancers, and CMV IE introns. Briefly, VR1405 was fected (cf Figures 3h and 5k,l) . Also not clear is the origin derived by cloning the ␤-galactosidase reporter gene into of the X-gal-positive 'banding' in myofibers (cf Figures the p-CMVint-Bl (blank) plasmid. 29 The sub-cloning of 6d,e and 8k). Such banding appears similar to the VR1207 has been previously described. 21 The p-CMVintreported band-shaped distribution of ribosomes associaBl plasmid has an SV40 poly(A) termination signal, ted with the myosin-containing A bands in skeletal whereas the VR1207 blank plasmid has a bovine growth muscle myofiber cells. 40 It has also been reported that hormone (BGH) gene-derived one. The VR1411 and ribosomal activity is high in the region of the myotendin-VR1412 lacZ constructs were derived by cloning a nuclear ous junction. 41 Thus, lacZ mRNA may be preferentially or cytoplasmic-targeted ␤-galactosidase gene into vector or primarily translated in certain regions of the VR1012, a modified version of VIJ-neo 44, 45 containing the myofiber cell.
kanamycin resistance gene and BGH poly(A) terminator. Quantification of X-gal-positive myofiber cells after a
The nuclear ␤-galactosidase gene in VR1411 was consingle injection of 50 g of lacZ DNA revealed that an structed by fusing the lacZ coding region at the 5′ end average of about 6% of rectus femoris myofiber cells were with an oligonucleotide encoding the SV40 large T antitransfected. In encircled areas of the muscle containing gen nuclear localization signal, MVKKKRK. the highest transfection levels, about 70% of the myofiber cells are routinely X-gal positive (eg counted in Figure  Plasmid DNA purification 3h). The number of transfected myofibers achieved in the Various plasmid constructs were transformed into E. coli present study using injections of 50 g lacZ DNA is
DH5a competent cells and grown in Terrific Broth 45 with higher than reported by others who obtained up to 60 X-100 g/ml ampicillin or 50 g/ml of kanamycin. Covalgal-positive fibers after injection of 200 g lacZ DNA.
1 In ently closed circular plasmid DNA was isolated by fact, the present transfection of up to 650 myofibers by double CsCl-ethidium bromide gradient ultracentrifugplasmid DNA injections is comparable to that achieved ation. The A 260 /A 280 ratios were typically 1.9. All plasmid using viral vectors 30 or using myoblast-mediated gene preparations were free of detectable chromosomal DNA transfer. 42, 43 By using plasmid DNA vectors encoding and RNA based on gel analysis and from protein murine (ie 'self') proteins in order to prevent an immune impurities based on the BCA assay. Endotoxin levels rejection of transfected myofiber cells, it may be possible ranged from 5 to 50 endotoxin units/mg plasmid DNA to increase greatly the proportion of persistently transbased on the LAL gel clot assay. 47 fected myofiber cells. Such increases in muscle transfection may eventually lead to experimental rationale for Intramuscular injections of plasmid DNA therapeutically effective injections of plasmid DNA encoThe quadriceps of restrained, awake mice were injected ding normal human dystrophin into human dystrophic with 50 l DNA solution using a disposable, plastic insumuscle.
lin syringe and a 28 G 1/2 needle (Becton-Dickinson In summary, the direct injection of a single dose of lacZ (Franklin Lakes, NJ, USA) Cat. No. BD9430) fitted with plasmid DNA into the mouse rectus femoris muscle a plastic collar cut from a yellow Eppendorf micropipette results in the immediate uptake and expression of the tip. The collar length was adjusted to limit the needle encoded ␤-galactosidase protein by an average of 6%, orifice penetration to a distance of 3 mm. The injection and up to 15% of the 4000 mouse rectus femoris myofiber was made 2 mm from the patellar tendon into the distal cells. Immediately following DNA injections, lacZ end for the rectus femoris muscle as described elseexpression initially appears near or at the myotendinous where. 44 Animal care throughout the study was in comjunction and then extends along the entire length of the pliance with the 'Guide for the Use and Care of Laboramyofiber cells. Thus, plasmid DNA injections can be an tory Animals', US Department of Health and Human effective means of distributing a gene product throughServices, National Institutes of Health (NIH Publication out entire myofiber cells. Furthermore, if plasmid DNA No. 86-23, revised 1985) . is internalized by undamaged myofiber cells via an active or passive uptake process, it may be possible chemically Extraction and assay of luciferase from mouse muscle The entire quadriceps muscle group (140-180 mg wet to stimulate DNA uptake in order to improve further myofiber cell transfection.
weight) was collected from each mouse leg at the indi-661 cated times after injection. Muscles were immediately frozen and stored at −78°C. Frozen muscles were thawed and extracted in Promega lysis buffer and assayed for luciferase as described. 21, 44 Uninjected control muscle extracts were prepared in the same manner and used in luciferase standard curve assays as described. 29, 44 Histochemical detection of ␤-galactosidase Mice were killed at 3, 6, 12 h, 1, 3, 4, 7, 14, 30 or 60 days by overdosing with sodium pentobarbital. Wholemount ␤-galactosidase detection was performed as described 48 with a few modifications. Briefly, quadriceps were removed from each mouse, fixed for 3 h at room temperature (RT) in 1% glutaraldehyde and 2% paraformaldehyde in sodium phosphate buffer (pH 7.3) containing 0.01% sodium deoxycholate and 0.02% Nonidet P-40, washed for 1 h in PBS containing 0.01% sodium deoxycholate and 0.02% Nonidet P-40, and incubated in reaction mixture containing 1 mg/ml 5-bromo-4-chloro-3-indolyl-␤-d-galactosidase (X-gal, GIBCO BRL), 2 mm MgCl 2 , 5 mm potassium ferriferrocyanide, 0.01% sodium deoxycholate, 0.02% Nonidet P-40 in sodium phosphate buffer (pH 7.3) at 37°C for 10-18 h. The X-gal was dissolved in dimethylformamide at 20 mg/ml, and then diluted into the reaction mixture. After incubation, quadriceps were washed three times for 10 min with 3% DMSO in PBS and stored in PBS at 4°C until analysis.
␤-Galactosidase-positive areas were identified at × 10-60 magnification under the dissecting microscope. The rectus femoris muscle of the mouse quadriceps group was the intended target of DNA injections. The three associated vastus muscles were dissected away from the rectus femoris after fixation and wholemount X-gal staining and generally did not exhibit lacZ expression. A few representative fixed and X-gal-stained muscles from each time-point were further separated into individual or clusters of myofibers using forceps under a dissecting microscope, collected on glass slides, examined for ␤-galactosidase expression by light microscopy, and representative fields were photographed. Some stripped fibers were airdried, counterstained with nuclear fast red, dehydrated in 80, 95, and 100% ethanol, cleared in xylene, and mounted with Permount (Fisher, Pittsburgh, PA, USA).
For detailed cross-sectional analysis, quadriceps were collected, embedded in OCT and frozen in liquid nitrogen-cooled isopentane. Each muscle was cut in half lengthwise. Eight m serial cryostat cross-sections were 
